iRadimed Corporation (NASDAQ:IRMD) is reporting third quarter financial results on Friday 30th October 2020, before market open.
According to analysts surveyed by Thomson Reuters, IRMD is expected to report 3Q20 income of $ 0.10 per share from revenue of $ 8.21 million.
For the full year, analysts anticipate top line of $ 33.24 million, while looking forward to income of $ 0.48 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 46.30 million ~ $ 47.10 million, where as bottomline are predicted in a range of $ 0.84 ~ $ 0.92 per share
Click Here For More Historical Outlooks Of iRadimed Corporation
Previous Quarter Performance
iRadimed Corporation disclosed income for the second quarter of $ 0.05 per share, from the revenue of $ 6.80 million. The quarterly earnings down 75.00 percent while revenues down 26.33 percent compared with the same quarter last year. Street analysts expected $ 6.44 million. The top line results outshined analysts by $ 0.36 million or 5.59 percent.
Stock Performance
Shares of iRadimed Corporation traded up $ 0.11 or 0.50 percent on Thursday, reaching $ 21.95 with volume of 18.60 thousand shares. iRadimed Corporation has traded high as $ 22.00 and has cracked $ 21.64 on the downward trend
According to the previous trading day, closing price of $ 21.95, representing a 51.46 % increase from the 52 week low of $ 14.42 and a 23.18 % decrease over the 52 week high of $ 28.43.
The company has a market capital of $ 268.81 million and is part of the Healthcare sector and Medical Devices industry.
Conference Call
iRadimed Corporation will be hosting a conference call at 11:00 AM eastern time on 30th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.iradimed.com
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also offers IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories.
